Padfield P L, Benediktsson R
Department of Medicine, Western General Hospital, Edinburgh, UK.
J Hum Hypertens. 1995 Jun;9(6):413-6.
Evidence from the medical literature is reviewed to indicate that ambulatory monitoring of blood pressure (ABPM) is a better predictor of target organ damage and clinical outcome in the hypertensive patient than clinic measurements of blood pressure (BP). A re-analysis of the documented BPs from the placebo limb of the Medical Research Council's treatment trial of mild hypertension is presented to indicate the difficulties inherent in the advice given by the various published guidelines on the diagnosis and management of hypertension. Finally, it is argued that because ABPM identifies a similar proportion of patients for treatment as a more prolonged follow-up, its use should be considered in the evaluation of all patients with mild hypertension as they can be categorised rapidly with less risk of being 'lost to follow-up'.
医学文献中的证据表明，对于高血压患者，动态血压监测（ABPM）比诊室血压测量（BP）能更好地预测靶器官损害和临床结局。本文对医学研究委员会轻度高血压治疗试验安慰剂组记录的血压进行重新分析，以指出各种已发表的高血压诊断和管理指南所给出建议中存在的固有困难。最后，有人认为，由于ABPM与更长时间的随访相比，能识别出相同比例的需要治疗的患者，因此在评估所有轻度高血压患者时应考虑使用ABPM，因为这样可以快速对患者进行分类，且“失访”风险较小。
